Drug developed in Turku blocks a notorious cancer driver
A research group at the Turku Centre for Biotechnology has found a novel way to inhibit a particularly vicious activity of one of the most notorious cancer drivers: the oncoprotein Ras.
Faron advances cancer immunotherapy with new co-operation
Finnish biopharmaceutical company Faron Pharmaceuticals has entered into an agreement with Swiss-based life science company Selexis.
Finnish spruce resin heals around the world
Spruce trees have a secret weapon: their resin fights off bacteria. Now these healing powers have been harnessed by Finland’s Repolar Pharmaceuticals and it is targeting international markets.
Biohit’s cancer preventative rolls out in Southeast Asia
Finnish biotechnology company Biohit has signed an agreement with Daiichi Sankyo (Thailand) for the exclusive distribution rights of Acetium capsules in Vietnam, Laos, Cambodia and Myanmar.
Biohit wins contract with Chinese Ministry of Health
Biohit’s GastroPanel biomarkers are to screen half a million 40–80-year-old asymptomatic persons in China, as part of gastric cancer risk screening study being organised in Chinese healthcare centres.
FIT Biotech to develop animal vaccines for China
The Finnish company FIT Biotech is starting up co-operation with the Chinese Qyh Biotech Company. The companies have signed an agreement concerning the development of several DNA vaccines for animals.
Finnish medical innovation to distribution in Russia
Finnish biotechnology company Biohit has signed a distribution agreement with Akeso Pharmaceuticals. Akeso, a pharmaceutical company marketing and distributing anti TB, anti-infectious and anticancer drugs, gains exclusive rights for the distribution of Acetium capsules in Russia.
Oncos Therapeutics attacks cancer cells with flu viruses
The goals that pharmaceutical startup Oncos Therapeutics has set itself are not exactly modest. The company’s objective is to tackle cancer by stimulating the human immune system with the help of the treatment it has developed.
Bayer relies on Finnish know-how
The most successful product ever to have left pharmaceutical company Bayer’s production plant in Turku dates back almost a quarter of a century and is sold in more than 120 countries. The company’s newest product is expected to be Finland’s next success story.